Human Milk Oligosaccharides Market Size, Share & Trends 2031
Human Milk Oligosaccharides Market Size, Share & Trends 2031
Segments - Human Milk Oligosaccharides Market by Type (2’FL, 3’SL, 3’FL, and 6’SL), Application (Food & Supplements, Infant Formula, Functional Food & Beverage, Bakery, Dairy, and Others), Distribution Channel (Drug Store or Pharmacy, Departmental Stores, Hypermarkets and Supermarkets, Mono-brand Stores, Mass Merchandiser, Specialty Stores, and Online Sales channel), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :FB-5735
| 4.7 Rating
| 54 Reviews
| 198 Pages
| Format :
Report Description
Human Milk Oligosaccharides Market Outlook 2031
The global human milk oligosaccharides market size was valued at USD 199.3 Million in 2022 and is likely to reach USD 1405.4 Million by 2031, expanding at a CAGR of 22.9% during, 2023 – 2031. The growth of the market is attributed to the rising awareness of the health benefits associated with human milk oligosaccharides (HMO).
Increasing global infant population is leading to the high demand for HMO added infant formulas and nutritional products, which boosts the human milk oligosaccharides market. HMOs, with their scientifically proven positive effects on health, are becoming a preferred choice for infant nutrition. Parents and caregivers understand that HMOs support digestive health, boost immunity, and contribute to overall well-being.
-
According to the reports published by the Centers for Disease Control and Prevention on June 8, 2023, states that 3664292 births in the US, resulting in a rate of 11 births per 1,000 population.
HMOs are natural complex carbohydrates found in human breast milk. These compounds are made up of simple sugar molecules linked together in various intricate arrangements. HMOs are primarily used by the baby's gut microbiota, which are beneficial bacteria in the digestive system. Additionally, they serve as a valuable source of nourishment for these beneficial bacteria, aiding in the development of a healthy gut microbiome.
The COVID-19 pandemic boosted the market. With concerns over the virus, mothers are seeking alternatives to direct breastfeeding, increasing the demand for infant formula products. This trend accelerated the utilization of HMO-fortified nutritional supplements and foods in infants and adults, further fueling the HMO market.
Impact of Artificial Intelligence (AI) on Human Milk Oligosaccharides Market
Emergence of artificial intelligence (AI) is expected to propel the market. AI-driven tools and automation enhance the efficiency of HMO production, ensuring better quality. This leads to increased availability of HMOs in various applications, including infant formula and health supplements. Furthermore, AI-driven data analysis and simulations expedite research into the benefits and applications of HMOs.
Human Milk Oligosaccharides Market Dynamics
Major Drivers
Rapidly expanding nutraceuticals industry is expected to drive the market. Nutraceuticals are products that combine the benefits of nutrition and pharmaceuticals, focusing on enhancing health and preventing disease.
Consumers are actively seeking nutritional supplements and health-enhancing foods that include HMOs as a natural ingredient. Furthermore, the growing demand for dietary supplements containing HMO is fueling the market.
-
According to a report published on February 15, 2022, 80% of the adult population in the US took dietary supplements in 2021.
Existing Restraints
High processing costs and complex manufacturing processes are expected to hinder the market. Manufacturing of HMOs in large quantities is costly and requires a lot of technical expertise. These high processing costs make HMO-fortified products expensive for consumers and limit their affordability and accessibility. Furthermore, the complex manufacturing processes create barriers for companies to expand their production capacity, thus hampering the market.
Emerging Opportunities
Ongoing research into the health benefits of HMOs is expected to create immense opportunities for the players competing in the market. This research is for innovation in product development, exploring applications in various health conditions, sports nutrition, and general well-being. The evolving scientific understanding of HMOs provides companies with create novel and effective products.
Scope of Human Milk Oligosaccharides Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Human Milk Oligosaccharides Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (2’FL, 3’SL, 3’FL, and 6’SL), Application (Food & Supplements, Infant Formula, Functional Food & Beverage, Bakery, Dairy, and Others), and Distribution Channel (Drug Store or Pharmacy, Departmental Stores, Hypermarkets and Supermarkets, Mono-brand Stores, Mass Merchandiser, Specialty Stores, and Online Sales channel) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott; BASF SE; Biosynth; Chr. Hansen Holding A/S; Dextra Laboratories Ltd; DuPont; Elicityl S.A.; Glycom A/S; and Inbiose NV |
Human Milk Oligosaccharides Market Segment Insights
Type Segment Analysis
Based on type, the human milk oligosaccharides market is divided into 2’fl, 3’sl, 3’fl, and 6’sl. The 2’fl segment is expected to hold a major market revenue share during the forecast period due to its well-documented health benefits.
2'FL is one of the most abundant and widely studied HMOs found in breast milk. It promotes digestive health and bolsters the immune system, making it an important component of infant nutrition. Moreover, research continually reaffirms the positive impact of 2'FL on infant health, which boosted the segment.
Application Segment Analysis
On the basis of application, the market is classified as food & supplements, infant formula, functional food & beverage, and, bakery, dairy, others. The infant formula segment is anticipated to expand at a robust pace owing to the increasing demand for the HMOs-based infant formula.
HMOs are naturally found in breast milk and offer various health benefits, such as supporting digestive health and enhancing the immune system. Parents are increasingly seeking HMO products that closely mimic the nutritional benefits of breast milk, which fuels the infant formula segment.
The food & supplements segment is projected to register a considerable CAGR during the forecast period due to the growing awareness and interest in food supplements containing HMOs. These supplements offer a convenient way to incorporate the health benefits of HMOs into daily dietary routines.
They promote gut health and support the body's natural defense mechanisms. Furthermore, rising awareness of HMOs' health benefits and their potential to enhance well-being in various age groups is propelling the segment.
Distribution Channel Segment Analysis
In terms of distribution channel, the human milk oligosaccharides market is fragmented into drug store or pharmacy, departmental stores, hypermarkets and supermarkets, mono-brand stores, mass merchandiser, specialty stores, and online sales channel.
The drug store or pharmacy segment is expected to hold a key share of the market during the projected period, as they are trusted and easily accessible sources for health-related products.
Consumers often turn to drug stores and pharmacies for a wide range of health and wellness items, including dietary supplements and nutritional products. Furthermore, drug stores and pharmacies typically employ knowledgeable staff who provide information and guidance to customers seeking specific health solutions. These factors drive the segment.
Regional Outlook
In terms of region, the global human milk oligosaccharides market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is expected to dominate the market due to the rapidly growing population, including a substantial number of infants.
HMOs are highly valued for infant nutrition and the region's expanding infant formula market is driving the demand for HMO-fortified products. For instance, according to the report published by the United Nations Children's Fund, approximately 30 million children are born in Asia Pacific.
The market in Europe is anticipated to expand at a rapid pace in the coming years due to the rising consumption of HMO products in this region. Consumers in Europe are increasingly becoming health-conscious and have a preference for natural and science-backed solutions. HMOs with their digestive health and immune-boosting properties fuel the market in this region.
Segments
The global human milk oligosaccharides market has been segmented on the basis of
Type
- 2’FL
- 3’SL
- 3’FL
- 6’SL
Application
- Food & Supplements
- Infant Formula
- Functional Food & Beverage
- Bakery
- Dairy
- Others
Distribution Channel
- Drug Store or Pharmacy
- Departmental Stores
- Hypermarkets and Supermarkets
- Mono-brand Stores
- Mass Merchandiser
- Specialty Stores
- Online Sales channel
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- BASF SE
- Biosynth
- Chr. Hansen Holding A/S
- Dextra Laboratories Ltd
- DuPont
- Elicityl S.A.
- Glycom A/S
- Inbiose NV
Competitive Landscape
Key players competing in the global human milk oligosaccharides market are Abbott; BASF SE; Biosynth; Chr. Hansen Holding A/S; Dextra Laboratories Ltd; DuPont; Elicityl S.A.; Glycom A/S; and Inbiose NV.
These companies are expanding their market share by implementing various strategies such as partnerships, acquisitions, mergers, reducing production costs, launching new products, and adopting advanced technologies.
- On November 16, 2021, Abbott, a multinational global healthcare leader, announced the launch of Similac 360 Total Care. This infant formula contains HMOs, which provides essential nutrition and components to support a baby's overall development and health. Similac 360 Total Care infant formula contains five different HMO blends, all of which are only found together in breast milk.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Milk Oligosaccharides Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Milk Oligosaccharides Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Milk Oligosaccharides Market - Supply Chain
4.5. Global Human Milk Oligosaccharides Market Forecast
4.5.1. Human Milk Oligosaccharides Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Milk Oligosaccharides Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Human Milk Oligosaccharides Market Absolute $ Opportunity
5. Global Human Milk Oligosaccharides Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Human Milk Oligosaccharides Market Size and Volume Forecast by Types
5.3.1. 2’FL
5.3.2. 3’SL
5.3.3. 3’FL
5.3.4. 6’SL
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Human Milk Oligosaccharides Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Human Milk Oligosaccharides Market Size and Volume Forecast by Applications
6.3.1. Food & Supplements
6.3.2. Infant Formula
6.3.3. Functional Food & Beverage
6.3.4. Bakery
6.3.5. Dairy
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Human Milk Oligosaccharides Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Human Milk Oligosaccharides Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Human Milk Oligosaccharides Demand Share Forecast, 2019-2026
8. North America Human Milk Oligosaccharides Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Human Milk Oligosaccharides Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Human Milk Oligosaccharides Market Size and Volume Forecast by Types
8.4.1. 2’FL
8.4.2. 3’SL
8.4.3. 3’FL
8.4.4. 6’SL
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Human Milk Oligosaccharides Market Size and Volume Forecast by Applications
8.7.1. Food & Supplements
8.7.2. Infant Formula
8.7.3. Functional Food & Beverage
8.7.4. Bakery
8.7.5. Dairy
8.7.6. Others
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Human Milk Oligosaccharides Demand Share Forecast, 2019-2026
9. Latin America Human Milk Oligosaccharides Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Human Milk Oligosaccharides Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Human Milk Oligosaccharides Market Size and Volume Forecast by Types
9.4.1. 2’FL
9.4.2. 3’SL
9.4.3. 3’FL
9.4.4. 6’SL
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Human Milk Oligosaccharides Market Size and Volume Forecast by Applications
9.7.1. Food & Supplements
9.7.2. Infant Formula
9.7.3. Functional Food & Beverage
9.7.4. Bakery
9.7.5. Dairy
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Human Milk Oligosaccharides Demand Share Forecast, 2019-2026
10. Europe Human Milk Oligosaccharides Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Human Milk Oligosaccharides Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Human Milk Oligosaccharides Market Size and Volume Forecast by Types
10.4.1. 2’FL
10.4.2. 3’SL
10.4.3. 3’FL
10.4.4. 6’SL
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Human Milk Oligosaccharides Market Size and Volume Forecast by Applications
10.7.1. Food & Supplements
10.7.2. Infant Formula
10.7.3. Functional Food & Beverage
10.7.4. Bakery
10.7.5. Dairy
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Human Milk Oligosaccharides Demand Share Forecast, 2019-2026
11. Asia Pacific Human Milk Oligosaccharides Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Human Milk Oligosaccharides Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Human Milk Oligosaccharides Market Size and Volume Forecast by Types
11.4.1. 2’FL
11.4.2. 3’SL
11.4.3. 3’FL
11.4.4. 6’SL
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Human Milk Oligosaccharides Market Size and Volume Forecast by Applications
11.7.1. Food & Supplements
11.7.2. Infant Formula
11.7.3. Functional Food & Beverage
11.7.4. Bakery
11.7.5. Dairy
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Human Milk Oligosaccharides Demand Share Forecast, 2019-2026
12. Middle East & Africa Human Milk Oligosaccharides Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Human Milk Oligosaccharides Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Human Milk Oligosaccharides Market Size and Volume Forecast by Types
12.4.1. 2’FL
12.4.2. 3’SL
12.4.3. 3’FL
12.4.4. 6’SL
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Human Milk Oligosaccharides Market Size and Volume Forecast by Applications
12.7.1. Food & Supplements
12.7.2. Infant Formula
12.7.3. Functional Food & Beverage
12.7.4. Bakery
12.7.5. Dairy
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Human Milk Oligosaccharides Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Human Milk Oligosaccharides Market: Market Share Analysis
13.2. Human Milk Oligosaccharides Distributors and Customers
13.3. Human Milk Oligosaccharides Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott
13.4.2. BASF SE
13.4.3. Biosynth
13.4.4. Chr. Hansen Holding A/S
13.4.5. Dextra Laboratories Ltd
13.4.6. DuPont
13.4.7. Elicityl S.A.
13.4.8. Glycom A/S
13.4.9. Inbiose NV
Methodology
Related Reports
Some other reports from this category!
Our Clients
